FDA lifts constraints on Glaxo diabetes drug Avandia (Reuters, 25 November 2013)

The US Food and Drug Administration (FDA) has announced it will lift certain restrictions placed on the diabetes drug Avandia (rosiglitazone). Full article FDA announcement
Source: Society for Endocrinology - Category: Endocrinology Source Type: news